Found: 11
Select item for more details and to access through your institution.
Erratum: Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial.
- Published in:
- 2012
- By:
- Publication type:
- Erratum
Effects of the Src Kinase Inhibitor Saracatinib (AZD0530) on Bone Turnover in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending-Dose Phase I Trial.
- Published in:
- Journal of Bone & Mineral Research, 2010, v. 25, n. 3, p. 463, doi. 10.1359/jbmr.090830
- By:
- Publication type:
- Article
Effect of an Aromatase Inhibitor on BMD and Bone Turnover Markers: 2-Year Results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) Trial (18233230).
- Published in:
- Journal of Bone & Mineral Research, 2006, v. 21, n. 8, p. 1215, doi. 10.1359/jbmr.060508
- By:
- Publication type:
- Article
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40061-y
- By:
- Publication type:
- Article
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Lipid profiles within the SABRE trial of anastrozole with and without risedronate.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 134, n. 3, p. 1141, doi. 10.1007/s10549-012-2147-9
- By:
- Publication type:
- Article
Biomarker Utility of Circulating Tumor Cells in Metastatic Cutaneous Melanoma.
- Published in:
- Journal of Investigative Dermatology, 2013, v. 133, n. 6, p. 1582, doi. 10.1038/jid.2012.468
- By:
- Publication type:
- Article
The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 1, p. 23, doi. 10.1007/s00280-007-0440-9
- By:
- Publication type:
- Article
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1248, doi. 10.1093/oncolo/oyad146
- By:
- Publication type:
- Article
Biomarkers in oncology drug development
- Published in:
- Molecular Oncology, 2009, v. 3, n. 1, p. 24, doi. 10.1016/j.molonc.2008.12.002
- By:
- Publication type:
- Article